Goldman Sachs analyst Asad Haider says investors are overreacting to the late-stage data Eli Lilly & Co (NYSE: LLY) reported for its experimental oral obesity pill, orforglipron, on Thursday.Lilly reported blockbuster results for the second quarter and raised its full-year guidance on August 7th.Still, the healthcare stock tumbled after management…
Asian stock markets rose on Friday, with a powerful rally in Japanese shares leading the way, as investors reacted…
India’s domestic institutional investors stepped in with their largest purchase of local stocks in four months on Thursday, providing…
European stock markets began Friday’s session with a mixed and somewhat hesitant performance, as a sharp drop in shares…
Higher prices dampened physical gold demand in major Asian centres this week, while also prompting some investors to sell…
Novo Nordisk shares rose over 5% in morning trade on Friday, ranking among the top gainers on the STOXX…
Global food commodity prices reached a two-year high in July, primarily due to increased international prices for meat and…
A coalition of 57 alcohol industry groups has warned President Donald Trump in a letter that a 15% tariff…
Walt Disney Co (NYSE: DIS) is inching down this morning after reporting mixed financial results for its third quarter.Investors…